• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconOzempic

Ozempic

Miami Beach Florida, CVS Pharmacy, pharmacist talking to customer, technician organizing medicine shelves.
Economy
U.S. demand for Novo Nordisk’s weight loss drugs is so huge that the Danish central bank just doubled the nation’s entire growth forecast
By Eleanor PringleSeptember 23, 2026
Brian Moynihan, chief executive officer of Bank of America
Success
Bank of America is splashing out $250 million a year on weight loss drugs for its staff: ‘We see a great impact on employees,’ CEO says
By Emma BurleighAugust 7, 2026
Pharmacy technician Brandy Leroy fills a TPN bag using the ExactaMix Pro Automated Compounding System
Startups & Venture
The FDA’s peptide vote could create telehealth’s next multibillion-dollar market
By Lily Mae LazarusJuly 20, 2026
Sean McClain wears a lab coat
Startups & Venture
Eli Lilly just placed a $40 million bet on the next injectable boom
By Lily Mae LazarusJuly 1, 2026
glp-wonderful
Success
Ozempic mania has even Olive Garden and The Cheesecake Factory cutting back on portion sizes
By Dee-Ann Durbin and The Associated PressMarch 12, 2026
Rich woman lounging on boat
Success
The wealthy 1% are turning to new status symbols that can’t be bought—and it’s hurting Dior, Versace, and Burberry
By Emma BurleighDecember 3, 2025
Donald Trump
Health
Trump punches new $35 billion hole in national debt with deal for Medicare to cover your Ozempic
By Nick LichtenbergNovember 6, 2025
A fruitist snack cup with jumbo-sized blueberries is depicted on a table.
C-Suite
Ray Dalio is backing a $1 billion blueberry unicorn that sells berries nearly the size of golf balls
By Eva RoytburgNovember 4, 2025
Adult obesity rate fell from record high—and big pharma is reaping the benefits from mainstream sales of weight-loss drugs like Zepound and Mounjaro
Health
Adult obesity rate fell from record high—and big pharma is reaping the benefits from mainstream sales of weight-loss drugs like Zepound and Mounjaro
By Matty Merritt and Morning BrewOctober 31, 2025
Ozempic
Health
Novo Nordisk slashes price of Ozempic in half to $499 for cash-paying, eligible U.S. patients
By Nick LichtenbergAugust 18, 2025
Ozempic
Commentary
Trump wants Medicare to pay for your Ozempic treatment. Taxpayers may foot the bill for billions in fraud
By Ari Yampolsky and Max VoldmanAugust 12, 2025
Exclusive: The founders of SoulCycle built a startup for relationships, then pivoted to GLP-1 support groups. Now its assets are being acquired by WeightWatchers
Newsletters
Exclusive: The founders of SoulCycle built a startup for relationships, then pivoted to GLP-1 support groups. Now its assets are being acquired by WeightWatchers
By Emma HinchliffeAugust 7, 2025
Novo Nordisk selects insider Maziar Mike Doustdar as new CEO, to tackle ‘recent market challenges’
C-Suite
Novo Nordisk selects insider Maziar Mike Doustdar as new CEO, to tackle ‘recent market challenges’
By AFPJuly 29, 2025
Novo Nordisk is losing Canadian patent protection on a blockbuster drug after not paying a small fee
Finance
Novo Nordisk is losing Canadian patent protection on a blockbuster drug after not paying a small fee
By Jason MaJune 17, 2025
Ozempic CEO’s exit from Novo started with Teams call surprise
Finance
Ozempic CEO’s exit from Novo started with Teams call surprise
By Naomi Kresge and BloombergMay 16, 2025
1
  • 1
  • 2
  • 3
  • 4
  • 5
...9
Most Popular
Personal Finance
After 40 investors rejected Jeff Bezos’ Amazon pitch, his parents offered $245,573 of their retirement savingsplaceholder alt text
By Marco Quiroz-GutierrezSeptember 22, 2026
Middle East
China suffers another setback in effort to de-dollarize global finance as anchor in the greenback's dominance quietly exits Beijing's payment schemeplaceholder alt text
By Jason MaSeptember 21, 2026
Success
'Skills nobody can take': Meet a 20-year-old with a 4.5 GPA who skipped college for technical school to land an 'AI-proof' careerplaceholder alt text
By Muskaan ArshadSeptember 22, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • TikTok icon
  • YouTube icon

    © 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
    FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.